Home>
US Stocks>
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc share price today

(RCKT)

Rocket Pharmaceuticals Inc share price is $13.89 & ₹1,175.69 as on 7 Dec 2024, 2.30 'hrs' IST

$13.89

▲

0.57

(4.28%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Rocket Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Rocket Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Rocket Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Rocket Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Rocket Pharmaceuticals Inc's financials.

Rocket Pharmaceuticals Inc share price movements

$13.44
$14.16
$13.89
3.24%
Downside
Day's Volatility :5.08%
Upside
1.91%
$12.62
$32.53
$13.89
9.14%
Downside
52 Weeks Volatility :61.2%
Upside
57.29%

Rocket Pharmaceuticals Inc Returns

Period	Rocket Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-32.49%	-5.7%	0.0%
6 Months	-40.4%	-0.8%	0.0%
1 Year	-47.21%	9.9%	0.0%
3 Years	-47.54%	10.7%	-19.7%

Rocket Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$13.32
Open	$13.44
Today's High	$14.16
Today's Low	$13.44
Market Capitalization	$1.2B
Today's Volume	$625.3K
52 Week High	$32.525
52 Week Low	$12.62
Revenue TTM	$0.0
EBITDA	$-264.8M
Earnings Per Share (EPS)	$-2.73
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-59.27%

How to invest in Rocket Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Rocket Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rocket Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Rocket Pharmaceuticals Inc or RCKT on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rocket Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rocket Pharmaceuticals Inc shares which would translate to 0.061 fractional shares of Rocket Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Rocket Pharmaceuticals Inc

89%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Rocket Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 89% more investors are searching Rocket Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Rocket Pharmaceuticals Inc

RTW INVESTMENTS, LLC
19.40%
Wellington Management Company LLP
12.33%
BlackRock Inc
6.79%
Vanguard Group Inc
6.07%
Westfield Capital Management Company, LP
4.93%
Maverick Capital Ltd
4.52%

Analyst Recommendation on Rocket Pharmaceuticals Inc

Buy

90%Buy

9%Hold

0%Sell

Based on 21 Wall street analysts offering stock ratings for Rocket Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 21 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rocket Pharmaceuticals Inc

What analysts predicted

Upside of 236.83%

Current:

$13.89

Target:

$46.79

Insights on Rocket Pharmaceuticals Inc

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 92.3%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 84.5%

Rocket Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Rocket Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rocket Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rocket Pharmaceuticals Inc	-24.23%	-40.4%	-47.21%	-47.54%	-42.04%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	11.44%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rocket Pharmaceuticals Inc	NA	NA	NA	-2.85	-0.59	-0.34	NA	3.62
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rocket Pharmaceuticals Inc	Buy	$1.2B	-42.04%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Rocket Pharmaceuticals Inc

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.

Organization	Rocket Pharmaceuticals Inc
Employees	268
CEO	Dr. Gaurav D. Shah M.D.
Industry	Health Technology

Management People of Rocket Pharmaceuticals Inc

Name	Title
Dr. Gaurav D. Shah M.D.	CEO & Director
Ms. Kinnari Patel M.B.A., Pharm.D.	Head of R&D, President & COO
Mr. Mayo Pujols	Chief Technical Officer
Mr. Jonathan Schwartz M.D.	Chief Medical & Gene Therapy Officer
Mr. Aaron Ondrey	Chief Financial Officer
Mr. Martin Louis Wilson J.D.	General Counsel, Chief Compliance Officer & Chief Corporate Officer
Kevin Giordano	Director of Corporate Communications
Ms. Isabel Carmona J.D.	Chief People Officer
Dr. Gayatri R. Rao J.D., M.D.	Senior VP of Clinical Safety & Chief Regulatory Officer
Mr. Raj Prabhakar M.B.A.	Chief Business Officer

Important FAQs about investing in Rocket Pharmaceuticals Inc from India :

What is Rocket Pharmaceuticals Inc share price today?

Rocket Pharmaceuticals Inc (RCKT) share price today is $13.89.

Can Indians buy Rocket Pharmaceuticals Inc shares?

Yes, Indians can invest in the Rocket Pharmaceuticals Inc (RCKT) from India.

With INDmoney, you can buy Rocket Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rocket Pharmaceuticals Inc at zero transaction cost.

How can I buy Rocket Pharmaceuticals Inc shares from India?

It is very easy to buy Rocket Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rocket Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Rocket Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Rocket Pharmaceuticals Inc stocks?

To start investing in Rocket Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.